Status:

RECRUITING

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Lead Sponsor:

Glaukos Corporation

Conditions:

Corneal Ectasia

Eligibility:

All Genders

18+ years

Brief Summary

The objectives of this post market registry are to evaluate the safety and durability of treatment effect up to 3 years following cross-linking performed with Photrexa Viscous (riboflavin 5'- phosphat...

Detailed Description

Approximately 200 patients who are planning to undergo or have undergone CXL for the treatment of corneal ectasia following refractive surgery in one or both eyes according to the prescribing informat...

Eligibility Criteria

Inclusion

  • Be at least 18 years of age, male or female, of any race;
  • Provide written informed consent and sign a HIPAA form;
  • Willingness and ability to follow all instructions and comply with schedule for study visits;
  • Have a diagnosis of corneal ectasia post-refractive surgery (such as LASIK, PRK);
  • Planning to undergo (or have undergone within the past 90 days) corneal collagen cross-linking with PHOTREXA VISCOUS/ PHOTREXA and the KXL System, per the prescribing information (NOTE: Complete treatment and follow-up data, including any product-related events at time of procedure through the time of enrollment must be available);
  • For females capable of becoming pregnant, agree to have urine pregnancy testing performed prior to enrolling in the registry; must not be pregnant or lactating.

Exclusion

  • If female, be pregnant, nursing, or have a positive urine pregnancy test prior to enrollment in the registry;
  • The Investigator may exclude or discontinue any patient for any sound medical reason.

Key Trial Info

Start Date :

October 4 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03319082

Start Date

October 4 2017

End Date

February 1 2026

Last Update

February 23 2024

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Stanford University School of Medicine

Palo Alto, California, United States, 94303

2

Chu Vision Institute, P.A.

Bloomington, Minnesota, United States, 55420

3

Vance Thompson Vision - MT

Bozeman, Montana, United States, 59718

4

Vance Thompson Vision - ND

West Fargo, North Dakota, United States, 58078

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery | DecenTrialz